Matches in Nanopublications for { ?s ?p "[Protein tyrosine kinase abnormalities, including translocations or mutations involving ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB, and FGFR1, have been used as the basis for classifying myeloproliferative neoplasms (MPN).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- NP187954.RAQta2rm5aJCpElQjT1VeSkzHFsSB9BEU0bw-vbqIJ_bM130_assertion description "[Protein tyrosine kinase abnormalities, including translocations or mutations involving ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB, and FGFR1, have been used as the basis for classifying myeloproliferative neoplasms (MPN).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187954.RAQta2rm5aJCpElQjT1VeSkzHFsSB9BEU0bw-vbqIJ_bM130_provenance.
- NP213317.RAgNqhAZDd1tXqbeUt7h-hIyaNj0EDpug-5_PgkaGXLTI130_assertion description "[Protein tyrosine kinase abnormalities, including translocations or mutations involving ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB, and FGFR1, have been used as the basis for classifying myeloproliferative neoplasms (MPN).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP213317.RAgNqhAZDd1tXqbeUt7h-hIyaNj0EDpug-5_PgkaGXLTI130_provenance.
- NP289089.RAeajPSSZOfYPXHdy5qHYRAi7imsmzBPWKepWfYwB44O8130_assertion description "[Protein tyrosine kinase abnormalities, including translocations or mutations involving ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB, and FGFR1, have been used as the basis for classifying myeloproliferative neoplasms (MPN).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP289089.RAeajPSSZOfYPXHdy5qHYRAi7imsmzBPWKepWfYwB44O8130_provenance.
- NP516372.RAqSAuftN6LzQHBql4cE95rXuIoUciV8yZM8b0WG-qNAk130_assertion description "[Protein tyrosine kinase abnormalities, including translocations or mutations involving ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB, and FGFR1, have been used as the basis for classifying myeloproliferative neoplasms (MPN).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP516372.RAqSAuftN6LzQHBql4cE95rXuIoUciV8yZM8b0WG-qNAk130_provenance.
- NP402457.RAYzyXxU2FQRmKQjRP6Pue4bk4rFyoYIFRWB5QqDJ7J6Y130_assertion description "[Protein tyrosine kinase abnormalities, including translocations or mutations involving ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB, and FGFR1, have been used as the basis for classifying myeloproliferative neoplasms (MPN).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402457.RAYzyXxU2FQRmKQjRP6Pue4bk4rFyoYIFRWB5QqDJ7J6Y130_provenance.
- NP422676.RAVdTqjMiDbGxzgTBvU3wMbN_NRQjN11fDJSlAsGLh4Zg130_assertion description "[Protein tyrosine kinase abnormalities, including translocations or mutations involving ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB, and FGFR1, have been used as the basis for classifying myeloproliferative neoplasms (MPN).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP422676.RAVdTqjMiDbGxzgTBvU3wMbN_NRQjN11fDJSlAsGLh4Zg130_provenance.
- NP524236.RAQOJYw4Y_lG2D2T6vrVEMhhAC17TAmDrWkX4RNA8FvRU130_assertion description "[Protein tyrosine kinase abnormalities, including translocations or mutations involving ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB, and FGFR1, have been used as the basis for classifying myeloproliferative neoplasms (MPN).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP524236.RAQOJYw4Y_lG2D2T6vrVEMhhAC17TAmDrWkX4RNA8FvRU130_provenance.
- NP576366.RAjfR7ExR6wt61IXG74l3VAZpL2qAz4M2y7scIRpODFFk130_assertion description "[Protein tyrosine kinase abnormalities, including translocations or mutations involving ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB, and FGFR1, have been used as the basis for classifying myeloproliferative neoplasms (MPN).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP576366.RAjfR7ExR6wt61IXG74l3VAZpL2qAz4M2y7scIRpODFFk130_provenance.
- NP518674.RA3PgRAOrJ3Ej4hzV2H74mUEE8w4FDFX_aXr_032t56TY130_assertion description "[Protein tyrosine kinase abnormalities, including translocations or mutations involving ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB, and FGFR1, have been used as the basis for classifying myeloproliferative neoplasms (MPN).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP518674.RA3PgRAOrJ3Ej4hzV2H74mUEE8w4FDFX_aXr_032t56TY130_provenance.
- NP416139.RA30QXTZ0yLMTRUmKbxa1FuS4wozwncSk0sPR0P2Nr13Y130_assertion description "[Protein tyrosine kinase abnormalities, including translocations or mutations involving ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB, and FGFR1, have been used as the basis for classifying myeloproliferative neoplasms (MPN).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP416139.RA30QXTZ0yLMTRUmKbxa1FuS4wozwncSk0sPR0P2Nr13Y130_provenance.
- assertion description "[Protein tyrosine kinase abnormalities, including translocations or mutations involving ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB, and FGFR1, have been used as the basis for classifying myeloproliferative neoplasms (MPN).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.